# Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major: A Multicenter, Prospective Clinical Study

> **NCT04009525** · PHASE4 · COMPLETED · sponsor: **First Affiliated Hospital of Guangxi Medical University** · enrollment: 823 (actual)

## Conditions studied

- Thalassemia Major

## Interventions

- **DRUG:** Busulfan
- **DRUG:** Cyclophosphamide
- **DRUG:** Fludarabine
- **DRUG:** Thymoglobulin
- **DRUG:** cyclosporine A
- **DRUG:** Mycophenolate mofetil
- **DRUG:** Tacrolimus
- **DRUG:** Methotrexate

## Key facts

- **NCT ID:** NCT04009525
- **Lead sponsor:** First Affiliated Hospital of Guangxi Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-05
- **Primary completion:** 2023-07-31
- **Final completion:** 2023-10-31
- **Target enrollment:** 823 (ACTUAL)
- **Last updated:** 2024-08-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04009525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04009525, "Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major: A Multicenter, Prospective Clinical Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04009525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*